home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

1,338 rows where filing_year = 2020 and issue_code = "MED" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, received_date (date)

filing_period 4

  • third_quarter 358
  • second_quarter 338
  • fourth_quarter 334
  • first_quarter 308

issue_code 1

  • MED · 1,338 ✖

filing_year 1

  • 2020 · 1,338 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
2420178 BOCKORNY GROUP, INC. 211e55f3-0237-4a52-996a-01bcb856593c 1T BOCKORNY GROUP, INC. 289773 ALLIANCE FOR CELL THERAPY NOW 2020 first_quarter MED Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act of FY2020 HOUSE OF REPRESENTATIVES,SENATE 60000   0 1 2020-02-10T11:48:08.740000-05:00
2420288 D.L. GARDNER AND ASSOCIATES 4999592f-19c5-4277-90d6-ae33c5a0aa9a Q1 D.L. GARDNER AND ASSOCIATES 401105409 CIPLA USA 2020 first_quarter MED funding for infectious disease research Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES 12500   0 0 2020-03-17T06:13:14.023000-04:00
2420290 D.L. GARDNER AND ASSOCIATES bdb90fc0-5066-4c24-96f7-e6fa75fa3c19 1T D.L. GARDNER AND ASSOCIATES 401105409 CIPLA USA 2020 first_quarter MED funding for infectious disease research Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES 12500   0 1 2020-03-17T06:21:21.280000-04:00
2420510 FRANCIS EDWARD & CRONIN, INC. 125ca5c2-f65a-4a08-8f6c-c2e4a1511304 Q1 FRANCIS EDWARD & CRONIN, INC. 311314 CURE ALZHEIMER'S FUND 2020 first_quarter MED Issues and legislation related to Alzheimer's disease research HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2020-04-01T10:08:32.540000-04:00
2420511 FRANCIS EDWARD & CRONIN, INC. 33e8293b-a123-47e2-8522-b6387dbb91dd Q1 FRANCIS EDWARD & CRONIN, INC. 311314 PATH DECISION SUPPORT SOFTWARE, LLC 2020 first_quarter MED Issues and legislation related to diabetes treatment and diagnosis HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE     0 0 2020-04-01T10:11:33.253000-04:00
2420552 AMERICAN COLLEGE OF CLINICAL PHARMACY 7ec9c022-a5a5-48ea-8f5b-be35876d8cd7 Q1 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2020 first_quarter MED Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   144981 0 0 2020-04-01T12:27:56.353000-04:00
2420794 MARSHALL BRACHMAN 87c27416-c4fd-4633-9658-7e4a21f463a9 Q1 MARSHALL BRACHMAN 6848 BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM 2020 first_quarter MED support funding for medical research programs HOUSE OF REPRESENTATIVES,SENATE 33000   0 0 2020-04-02T15:34:40.220000-04:00
2420961 FEDERAL SOLUTIONS, LLC 7a78f251-8bc6-4b9d-9493-c6f060cda578 Q1 FEDERAL SOLUTIONS, LLC 311371 MISSISSIPPI STATE UNIVERSITY 2020 first_quarter MED Labor/HHS/Education Appropriations: Provisions relating to disease research. Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Oceanic & Atmospheric Administration (NOAA),SENATE 50000   0 0 2020-04-03T13:53:45.383000-04:00
2421087 ATLAS ADVOCACY 284498c9-3bcb-4a4f-8823-2786ba17ab32 Q1 ATLAS ADVOCACY 401100069 BLADDER CANCER ADVOCACY NETWORK 2020 first_quarter MED CDMRP; Disease Awreness resolution HOUSE OF REPRESENTATIVES,SENATE 9000   0 0 2020-04-03T17:07:24.797000-04:00
2421218 AUBURN HEALTH STRATEGIES, LLC d142503b-d20c-4576-8de0-704c4f8eed55 Q1 AUBURN HEALTH STRATEGIES, LLC 292697 NEUROTECH, LLC 2020 first_quarter MED EEG monitoring Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE     0 0 2020-04-05T19:30:22.247000-04:00
2421231 ACUITY STRATEGIC PARTNERS LLC c0b5c184-b17e-4df3-a2c5-62ad40daa681 Q1 ACUITY STRATEGIC PARTNERS LLC 401105363 AMICUS THERAPEUTICS, INC. 2020 first_quarter MED Reimbursement for rare disease patient care HOUSE OF REPRESENTATIVES,SENATE     0 0 2020-04-06T08:44:46.997000-04:00
2421236 COMMONWEALTH POLICY SOLUTIONS 3a73a81e-c109-4e0e-8b8d-c4afd336f90a Q1 COMMONWEALTH POLICY SOLUTIONS 401105004 RARE ACCESS ACTION PROJECT 2020 first_quarter MED Reimbursement for rare disease patient care HOUSE OF REPRESENTATIVES,SENATE 12000   0 0 2020-04-06T08:48:48.217000-04:00
2421237 COMMONWEALTH POLICY SOLUTIONS f9aa73d5-cc71-44dc-857f-91d24dccbf17 Q1 COMMONWEALTH POLICY SOLUTIONS 401105004 TRISALUS LIFE SCIENCES 2020 first_quarter MED Medical device development for oncology, drug delivery for oncology HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2020-04-06T08:49:49.423000-04:00
2421351 SQUIRE PATTON BOGGS b77b75f7-eda5-42d7-8192-a563cac59a99 Q1 SQUIRE PATTON BOGGS 30906 UNIVERSITY OF GEORGIA 2020 first_quarter MED Traumatic brain injury research, funding, and outreach opportunities. Research related to emerging and infectious diseases. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2020-04-06T11:45:46.573000-04:00
2421368 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) 39f411ed-bdad-4afd-b854-d93bcebca3e9 Q1 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) 400361684 PPLA 2020 first_quarter MED Pharmaceutical labeling Food & Drug Administration (FDA) 18700   0 0 2020-04-06T12:56:03.200000-04:00
2421692 MANATT, PHELPS, AND PHILLIPS 9729928d-f9de-42e2-a9ad-ab1b08370cfb 1T MANATT, PHELPS, AND PHILLIPS 23645 SCIENCE CARE, INC. 2020 first_quarter MED H.R. 1835 Consensual Donation and Research Integrity Act of 2019 HOUSE OF REPRESENTATIVES,SENATE 20000   0 1 2020-04-07T13:15:12.867000-04:00
2421702 SQUIRE PATTON BOGGS 8cc05251-61d9-4df5-99d1-3a2ea45adc44 Q1 SQUIRE PATTON BOGGS 30906 IMPACT JOURNALS, LLC 2020 first_quarter MED National Library of Medicine indexing matters. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2020-04-07T13:34:28.923000-04:00
2421786 SQUIRE PATTON BOGGS 0d915b6d-1336-4a22-b8bb-f2ce479887fd Q1 SQUIRE PATTON BOGGS 30906 ALLIANCE FOR BIOSECURITY 2020 first_quarter MED Preparedness and response as it relates to Biosecurity. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 100000   0 0 2020-04-07T14:19:19.907000-04:00
2421812 SQUIRE PATTON BOGGS 46e92b70-ee68-41cb-a069-ecb5e1c2b270 Q1 SQUIRE PATTON BOGGS 30906 NATIONAL CANNABIS ROUNDTABLE 2020 first_quarter MED Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use. HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of,White House Office 120000   0 0 2020-04-07T14:34:38.610000-04:00
2421993 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 51f19d84-0b6f-4b5b-8d24-7f1c487b5ca4 Q1 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 1466 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 2020 first_quarter MED On February 28, 2020 AACC wrote to the Food and Drug Administration requesting that the agency permit laboratories develop laboratory developed tests to detect COVID-19 without having to obtain an Emergency Use Authorization from the agency. On March 25, 2020 AACC wrote to the Department of Health and Human Services requesting that pathologists and related staff be permitted to work offside during the COVID-19 pandemic under their existing CLIA lab certificate. On March 27, 2020 AACC endorsed S.3512, the Verified Innovative Testing in American Laboratories (VITAL) Act, which would codify federal regulation of laboratory developed tests under the Clinical Laboratory Improvement Amendment regulations overseen by the Centers for Medicare and Medicaid Services. Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   70000 0 0 2020-04-08T10:55:21.433000-04:00
2422294 WAKE FOREST UNIVERSITY HEALTH SCIENCES df6ffb09-b5a1-45d8-8328-914de327965d Q1 WAKE FOREST UNIVERSITY HEALTH SCIENCES 6781 WAKE FOREST UNIVERSITY HEALTH SCIENCES 2020 first_quarter MED FY21 Department of Labor/HHS Appropriations bill Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   150000 0 0 2020-04-09T09:42:12.707000-04:00
2422400 UPSTREAM CONSULTING, INC. 3a43f7fb-44d6-4177-847b-c00164406d1d Q1 UPSTREAM CONSULTING, INC. 88278 RARE ACCESS ACTION PROJECT 2020 first_quarter MED Reimbursement coverage by Medicaid and Medicare for rare disease therapies. HOUSE OF REPRESENTATIVES,SENATE 8000   0 0 2020-04-09T11:59:40.340000-04:00
2423344 CASSIDY & ASSOCIATES, INC. e52e60eb-5e80-4f0c-912b-eac314b25b0a Q1 CASSIDY & ASSOCIATES, INC. 8453 ONE HEALTH SOLUTIONS, LLC 2020 first_quarter MED HR 6074 Coronavirus Preparedness and Response Supplemental Appropriations Act HR 6201 Families First Coronavirus Response Act HR 748 CARES Act Telehealth Issues Agriculture, Dept of (USDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,U.S. Agency for International Development (USAID) 60000   0 0 2020-04-10T23:52:30.190000-04:00
2423414 REPUBLIC CONSULTING, LLC 6255e1be-ca8b-4b8d-9333-051088e2d213 Q1 REPUBLIC CONSULTING, LLC 401016871 IQVIA 2020 first_quarter MED Monitor Data and Science policy. Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2020-04-11T14:13:24.893000-04:00
2423694 K&L GATES, LLP 59af1f17-835c-43b7-b04a-1f979eee0e65 Q1 K&L GATES, LLP 32098 NATIONAL ASSN FOR BIOMEDICAL RESEARCH 2020 first_quarter MED Issues related to medical research (no legislation). HOUSE OF REPRESENTATIVES,SENATE,Transportation, Dept of (DOT) 20000   0 0 2020-04-13T10:51:13.457000-04:00
2423874 GREEN PLAINS INC. 54b70154-3cfa-48df-bd68-cbfd992efe63 Q1 GREEN PLAINS INC. 401104765 GREEN PLAINS 2020 first_quarter MED Issues related to the Novel Coronavirus and the disease COVID-19; Issues related to the production of industrial grade alcohol for inclusion in hand sanitizer; Issues related to the transportation and tax treatment for industrial grade alcohol for inclusion in hand sanitizer; H.R. 748, the CARES Act Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Energy, Dept of,Environmental Protection Agency (EPA),Federal Emergency Management Agency (FEMA),Federal Motor Carrier Safety Administration,Food & Drug Administration (FDA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),SENATE,Transportation, Dept of (DOT),Treasury, Dept of,U.S. Trade Representative (USTR),White House Office   190000 0 0 2020-04-13T12:11:47.367000-04:00
2424198 RAY C CULVER III 0e4617d7-3799-4e39-908b-d8495f2970ea Q1 RAY C CULVER III 11468 ARKANSAS CHILDREN'S HOSPITAL 2020 first_quarter MED Funding for USDA ARS Human Nutrition Research Centers in the FY2021 House and Senate Agricultural Appropriations bills HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2020-04-13T15:30:43.300000-04:00
2424460 KUTAK ROCK LLP 6152dfe2-42eb-415a-a881-3099d6e74fb9 Q1 KUTAK ROCK LLP 21962 NE ENTERPRISES 2020 first_quarter MED Reauthorization of Pandemic and All Hazards Preparedness Act and related matters   20000   0 0 2020-04-13T18:01:00.427000-04:00
2424497 THE PETRIZZO GROUP, INC. 95ab2487-2887-4dd1-842b-f20cca7f0ec9 Q1 THE PETRIZZO GROUP, INC. 305932 CEL-SCI CORPORATION 2020 first_quarter MED Activity related to phase III clinical trial in head and neck cancer to boost the immune system before the ravages of surgery, radiation and chemotherapy. The Phase III trial is the largest ever in head and neck cancer with 928 patients enrolled. Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 50000   0 0 2020-04-13T20:28:09.953000-04:00
2424507 THE PETRIZZO GROUP, INC. 82584681-b9cc-4370-b2e4-3b984dd26757 Q1 THE PETRIZZO GROUP, INC. 305932 ALLEN INSTITUTE 2020 first_quarter MED Advocated for funding of the BRAIN Initiative, Alzheimer's research full funding for NIH. Advocated for the development of open data hosting, and integrated, scalable data analysis hubs for the BRAIN Initiative at NIH. The Human Projectome Project, a comprehensive Atlas of cell types in human brain and the Mouse Connectome Project for BRAIN Initiative Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office 50000   0 0 2020-04-13T22:02:12.590000-04:00
2424571 AMERICAN SOCIETY OF ADDICTION MEDICINE a8458d84-4311-44d2-a53b-94eb5524e2fa Q1 AMERICAN SOCIETY OF ADDICTION MEDICINE 401104864 AMERICAN SOCIETY OF ADDICTION MEDICINE 2020 first_quarter MED Advocated for FY2021 Labor HHS Appropriations bill - appropriations related to strengthening the addiction services workforce, including full funding of the loan repayment program for the substance use disorder treatment workforce authorized in the SUPPORT Act, increase in funding for the mental and substance use disorders training demonstration program authorized in 21st Century Cures Act, funding for preventive medicine residency programs, and $8.8 billion for discretionary Health Resources and Services Administration programs. Supported HR 3414 (and prior versions)/ S. 2892 - Opioid Workforce Act of 2019 - bill increases the number of residency positions eligible for graduate medical education payments under Medicare for hospitals that have addiction or pain management programs, with an aggregate increase of 1,000 positions over a five-year period. Supported HR 3165 and S 1737 - Mental Health Parity Compliance Act - strengthen parity in mental health and substance use disorder benefits. Advocated for its inclusion in the Lower Health Care Costs Act of 2019. Supported S 873 and HR 1879 - Stabilize Medicaid and CHIP Coverage Act which would provide for 12 months of continuous enrollment in Medicaid and CHIP to ensure better access to care and reduce churn. This bill is not specific to mental health, but it would provide significant stability to those patients and providers. Supported H.R.1920 - Medicaid Bump Act - To amend title XIX of the Social Security Act to provide a higher Federal matching rate for increased expenditures under Medicaid for mental and behavioral health services, and for other purposes. Supported H.R.1329 - Medicaid Reentry Act - This bill allows Medicaid payment for medical services furnished to an incarcerated individual during the 30-day period preceding the individual's release. Supported S 824/HR 1767 - Excellence in Mental Health and Addiction Treatment Expansion Act This legislation would extend and expand the Certified Community Behavioral Health Clinic (CCBHC) demonstration… Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA)   80000 0 0 2020-04-14T06:57:26.107000-04:00
2424598 HACKENSACK MERIDIAN HEALTH 8086c06c-242a-4680-b5d6-1b85ac656e81 Q1 HACKENSACK MERIDIAN HEALTH 401104109 HACKENSACK MERIDIAN HEALTH 2020 first_quarter MED National Institutes of Health funding Behavioral health Substance abuse, opioids, and patient data Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   40000 0 0 2020-04-14T07:54:32.923000-04:00
2424633 MUNK POLICY & LAW ec7c5e25-98ed-435c-b7da-5376ef4b8ea9 Q1 MUNK POLICY & LAW 401105075 SOUTHERN METHODIST UNIVERSITY 2020 first_quarter MED Traumatic Brain Injury Research HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2020-04-14T09:36:52.007000-04:00
2424876 MCDERMOTT+ LLC 319cb952-e09b-4b32-ad3a-0e2f786dcf10 Q1 MCDERMOTT+ LLC 401103287 COALITION FOR 21ST CENTURY MEDICINE 2020 first_quarter MED Issues concerning regulation of laboratory-developed tests. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 40000   0 0 2020-04-14T11:50:48.610000-04:00
2424951 ISEMAN & ASSOCIATES LLC 43a8d74e-2b36-48d1-82cf-f52d9a5fe37c Q1 ISEMAN & ASSOCIATES LLC 401103582 TICHENOR VENTURES, LLC 2020 first_quarter MED Monitoring biotech legislation HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2020-04-14T12:30:12.947000-04:00
2424969 ISEMAN & ASSOCIATES LLC 9abad2a2-99b4-41ec-9218-709b8359f5c8 1T ISEMAN & ASSOCIATES LLC 401103582 PILLNURSE, LLC 2020 first_quarter MED Medical device funding HOUSE OF REPRESENTATIVES,SENATE 22500   0 1 2020-04-14T12:40:19.193000-04:00
2425169 SQUIRE PATTON BOGGS 3788506a-9cd6-4a02-ade7-208748d201b0 Q1 SQUIRE PATTON BOGGS 30906 LA MAESTRA FOUNDATION ON BEHALF OF LA MAESTRA FAMILY CLINIC, INC. 2020 first_quarter MED Health care public policy and regulatory advocacy matters HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2020-04-14T15:08:27.297000-04:00
2425323 AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION fd3dcc33-0efd-4a0a-93f1-e53de890c714 Q1 AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION 401103437 AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION 2020 first_quarter MED HR 1379 IT Strategic Health Plan Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES     0 0 2020-04-14T16:15:14.947000-04:00
2425385 BLUEBIRD STRATEGIES 884035c9-e6b5-460c-8658-91f18b3433ab Q1 BLUEBIRD STRATEGIES 401105447 MYRIAD GENETICS, INC. 2020 first_quarter MED Legislation to regulate clinical labs under CLIA and FDA. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2020-04-14T16:44:38.050000-04:00
2425392 BLUEBIRD STRATEGIES 4aebdff9-846e-49a5-af65-defab58de0f8 Q1 BLUEBIRD STRATEGIES 401105447 MYOTONIC 2020 first_quarter MED Increasing funding for Myotonic Dystrophy research. Fiscal year 2020 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2020-04-14T16:48:39.983000-04:00
2425502 THE PETRIZZO GROUP, INC. ae132bae-6d19-4651-8571-a9c575bc9b9b Q1 THE PETRIZZO GROUP, INC. 305932 OMEROS CORPORATION 2020 first_quarter MED Advocated for Medicare Part B packaged payment reforms; and the expansion of the non-opioid pain management drug exclusion to the drugs functioning as supplies during a surgical procedure packaging policy. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 80000   0 0 2020-04-14T23:54:26.040000-04:00
2425503 THE PETRIZZO GROUP, INC. 796a730c-4333-4c85-9fc1-b427731e3389 Q1 THE PETRIZZO GROUP, INC. 305932 SEATTLE CHILDREN'S HOSPITAL RESEARCH AND FOUNDATION 2020 first_quarter MED Funding for NIH research; H.R. 4159, PACT Act. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 50000   0 0 2020-04-15T00:00:26.713000-04:00
2425527 AMERICAN PHYSICAL THERAPY ASSOCIATION f6cb1bc2-062d-425e-bad5-d0652de9aa28 Q1 AMERICAN PHYSICAL THERAPY ASSOCIATION 3093 AMERICAN PHYSICAL THERAPY ASSOCIATION 2020 first_quarter MED NIH Rehab issues APTA role with NIH Traumatic brain injury research Support of work done at CDC Injury Center on elder adult falls, TBI, youth sports concussions NIH Research and Development funding Physical Therapist role in childhood obesity Relocate TBI State Grant Program to ACL NIDILRR - Rehab research Nomination to NIH Committees Safety of Children in School (Restraint & Seclusion) Falls and Falls Prevention Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Education, Dept of,Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,Small Business Administration (SBA),Social Security Administration (SSA),Veterans Affairs, Dept of (VA),White House Office   271987 0 0 2020-04-15T08:26:36.737000-04:00
2425550 THOMPSON ADVISORY GROUP 844b7db2-cf6b-463d-a6a7-cc67b9ac4bbd Q1 THOMPSON ADVISORY GROUP 319610 SONNET BIOTHERAPEUTICS 2020 first_quarter MED medical research SENATE 20000   0 0 2020-04-15T09:03:45.093000-04:00
2425681 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. fc2631c7-35d7-4441-afba-14a7fff76984 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION 2020 first_quarter MED Research Opportunities at the Department of Defense, the National Institutes of Health, and the Centers for Disease Control and Prevention FY21 Defense Appropriations Act, DoD research on vascular malformations FY21 Labor-HHS-Education Act, NIH and CDC research on HHT HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 10000   0 0 2020-04-15T10:14:27.073000-04:00
2425690 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. e22213ab-ef89-435c-b737-3435d7115f34 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 PANCREATIC CANCER ACTION NETWORK (PANCAN) 2020 first_quarter MED cancer research at DOD and NIH HR 2968; S 2474 Department of Defense Appropriations Act 2020, pancreatic cancer research HR 1158, Consolidated Appropriations Act, DoD medical research funding for pancreatic cancer HR 2740, Labor, HHS, Education, Defense, State, Foreign Operations & Energy & Water HR 1865, Further Consolidated Appropriations Act, NIH funding for pancreatic cancer research Development Appropriations Act 2020, NIH research in pancreatic cancer Peer Reviewed Medical Research HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 40000   0 0 2020-04-15T10:17:30.293000-04:00
2425692 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. ab030690-10de-4861-b778-2a3a522594a4 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 FOUNDATION FOR PERIPHERAL NEUROPATHY 2020 first_quarter MED FY21 Defense Appropriations Act, DoD funding for peripheral neuropathy research HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2020-04-15T10:21:31.600000-04:00
2425740 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8699bf0e-92c1-4607-a192-e1648ba773c3 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 TUBEROUS SCLEROSIS ALLIANCE 2020 first_quarter MED FY21 Defense Appropriations Act, Tuberous Sclerosis Complex Research Program FY21 Labor-HHS-Appropriations Act, NIH and CDC research on tuberous sclerosis complex NIH research on tuberous sclerosis complex HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2020-04-15T10:36:44.070000-04:00
2425787 EFB ADVOCACY, LLC 3da02cc2-0847-499a-8134-07f3469affbe Q1 EFB ADVOCACY, LLC 401104430 UNITED FOR MEDICAL RESEARCH 2020 first_quarter MED Funding Issues Related to the National Institutes of Health HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2020-04-15T10:47:59.287000-04:00
2425978 GIBBONS P.C. ccd67d05-0828-4819-9414-80b21e1f4d7c Q1 GIBBONS P.C. 89873 BERGEN ANESTHESIA GROUP P.C. 2020 first_quarter MED Seeking amendments to Surprise Medical Billing Legislation. HOUSE OF REPRESENTATIVES,SENATE,White House Office 40000   0 0 2020-04-15T11:52:08.697000-04:00
2426132 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 968bf36f-e38e-4918-a9a4-36277166828e Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 DEFENSE HEALTH RESEARCH CONSORTIUM 2020 first_quarter MED Y21 Defense Appropriations Act, Defense Health Research Programs FY21 National Defense Authorization Act, Defense Health Research Programs HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2020-04-15T12:26:57.013000-04:00
2426194 GOVERNMENT COUNSEL, LLC d1708ab9-08fe-4f99-8a74-4399557f9a9c Q1 GOVERNMENT COUNSEL, LLC 401105070 HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS) 2020 first_quarter MED H.R.6102 & S.3404-Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2020-04-15T12:44:14.467000-04:00
2426257 WATKINS & EAGER PLLC 1d0f8bbb-2474-4024-bd04-b7c5b59a78c8 Q1 WATKINS & EAGER PLLC 401104403 NATIONAL FRAGILE X FOUNDATION 2020 first_quarter MED Work to assist in developing a legislative strategy for funding for training & development for Fragile X clinicians & other medical providers. Encourage Members to act favorably on matters of interest related to funding & research. HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2020-04-15T12:58:33.417000-04:00
2426849 MANATOS & MANATOS 5c91df18-1a90-4094-9331-e193116bd6c7 Q1 MANATOS & MANATOS 23634 BARBARA ANN KARMANOS CANCER INSTITUTE 2020 first_quarter MED PPS-exempt cancer hospitals HOUSE OF REPRESENTATIVES,SENATE     0 0 2020-04-15T15:49:20.200000-04:00
2427067 MEHLMAN CONSULTING, INC. 281648fd-82e4-47d5-922d-de34eb453af2 Q1 MEHLMAN CONSULTING, INC. 284950 AEGIS SCIENCES CORPORATION 2020 first_quarter MED H.R. 748, the Coronavirus Aid, Relief, and Economic Security (CARES) Act - Public Law No: 116-136; Provisions related to coverage of diagnostic testing Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2020-04-15T17:22:22.667000-04:00
2427145 BOCKORNY GROUP, INC. debbdcf6-9708-4026-b0e3-a4ef4905ebee 1@ BOCKORNY GROUP, INC. 289773 ALLIANCE FOR CELL THERAPY NOW 2020 first_quarter MED Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act of FY2020 HOUSE OF REPRESENTATIVES,SENATE 20000   0 1 2020-04-15T18:00:50.843000-04:00
2427251 THE WATTS GROUP PLLC f3ceb225-c616-43ba-8c20-627057d3273e 1T THE WATTS GROUP PLLC 401105118 NOVARTIS 2020 first_quarter MED Gene therapy innovation HOUSE OF REPRESENTATIVES,SENATE 60000   0 1 2020-04-15T23:21:20.163000-04:00
2427497 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 7e0fd076-e271-4082-b3e5-da2626da6471 1T CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL HEMOPHILIA FOUNDATION 2020 first_quarter MED Hemophilia research, prevention, surveillance and service programs and issues Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 50000   0 1 2020-04-16T09:50:28.300000-04:00
2427529 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 827811d9-41a5-4d80-b3cc-c4bd38949810 1T CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL ASSOCIATION OF EPILEPSY CENTERS 2020 first_quarter MED Research and public health programs in epilepsy. Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 10000   0 1 2020-04-16T09:56:37.020000-04:00
2427661 CONGRESSIONAL SOLUTIONS, INC (CSI) 8145cf3e-3a5a-447b-b9cb-8394d0ac872f 1A CONGRESSIONAL SOLUTIONS, INC (CSI) 297237 UNIVERSITY OF NORTH TEXAS SYSTEM 2020 first_quarter MED COVID19 Research Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2020-04-16T10:40:07.897000-04:00
2427672 FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) 763b69fc-45b6-47bd-8410-23df7e4ed0b5 Q1 FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) 86196 COLOR HEALTH (FKA COLOR GENOMICS) 2020 first_quarter MED Lobbying related to healthcare issues. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2020-04-16T10:43:09.630000-04:00
2427679 THE CONAFAY GROUP, LLC 2b09f41d-c6f6-41b7-a507-0cc476c2ea34 Q1 THE CONAFAY GROUP, LLC 401004840 HAWAII BIOTECH, INC. 2020 first_quarter MED Medical countermeasures. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2020-04-16T10:49:24.987000-04:00
2427746 O'NEILL AND ASSOCIATES 6a5aaf40-f1b5-46b0-b4ba-93e5314088a4 Q1 O'NEILL AND ASSOCIATES 73134 POINT32HEALTH SERVICES, INC. (FORMERLY TUFTS HEALTH PLAN) 2020 first_quarter MED Medical HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2020-04-16T11:07:43.480000-04:00
2427758 THE CONAFAY GROUP, LLC 5accf944-29c1-4787-bebe-39b1c3365597 1T THE CONAFAY GROUP, LLC 401004840 XERIS PHARMACEUTICALS, INC. 2020 first_quarter MED Biomedical research issues HOUSE OF REPRESENTATIVES 10000   0 1 2020-04-16T11:10:47.700000-04:00
2427814 O'NEILL AND ASSOCIATES cbb1cf71-e6f3-4feb-bafb-578d47b3f31b Q1 O'NEILL AND ASSOCIATES 73134 ANALOGIC 2020 first_quarter MED Medical Technology HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2020-04-16T11:19:01.963000-04:00
2427821 FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) b8a040ae-1e36-48d9-80d1-13b16c1b195f Q1 FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) 86196 INTUITIVE SURGICAL, INC. 2020 first_quarter MED Lobbying related to health care issues. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2020-04-16T11:20:03.567000-04:00
2427831 LNE GROUP ec049d68-7cf6-4fad-a7bd-792180252a0e Q1 LNE GROUP 308811 HOSPICE OF THE WESTERN RESERVE 2020 first_quarter MED lobbied for medical issues Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)     0 0 2020-04-16T11:22:06.233000-04:00
2427841 LNE GROUP f1191b7b-8d42-4382-b013-5ea2b22f5d4b Q1 LNE GROUP 308811 OHIOGUIDESTONE (FORMALLY KNOWN AS GUIDESTONE) 2020 first_quarter MED lobbied for medical issues Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2020-04-16T11:23:08.090000-04:00
2427919 THE CONAFAY GROUP, LLC 7d09cf44-21de-4b96-93ea-3206df18979c Q1 THE CONAFAY GROUP, LLC 401004840 EMERGEX VACCINES HOLDING LTD. 2020 first_quarter MED Influenza and respiratory disease research HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2020-04-16T11:34:25.910000-04:00
2427978 LNE GROUP fcf842d3-1a6d-40ea-80ba-b1211f1c91df Q1 LNE GROUP 308811 UNIVERSITY HOSPITALS HEALTH SYSTEM 2020 first_quarter MED lobbied for medical issues Bureau of Industry and Security (BIS),Commerce, Dept of (DOC),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2020-04-16T11:45:45.937000-04:00
2428199 THE JACKSON LABORATORY 145219e7-67cb-4b12-ace1-5fffca36990c Q1 THE JACKSON LABORATORY 401104723 THE JACKSON LABORATORY 2020 first_quarter MED Issues pertaining to basic science research and biomedical research. The background and use of animal models in biomedical research. National Institutes of Health and the Federal Bureau of Investigation scrutinizing researchers with global research collaborations. Issues pertaining to COVID-19 diagnosis and model discovery. HOUSE OF REPRESENTATIVES,SENATE,Transportation, Dept of (DOT)   30000 0 0 2020-04-16T12:16:29.277000-04:00
2428354 GREENBERG TRAURIG, LLP 25f8fd43-b423-4d44-bd3c-fdcca8e7fcf3 Q1 GREENBERG TRAURIG, LLP 16896 AMERICAN SOCIETY INTERVENTIONAL PAIN PHYSICIANS 2020 first_quarter MED Outreach and monitoring related to the implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). Outreach and monitoring related to federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER) (P.L. 109-60). Outreach and monitoring related to federal and legislative activity related to Medicare Reimbursement and Medicare Advantage Reimbursement. Outreach and monitoring related to federal issues and legislation associated with health care policy. Outreach and monitoring related to federal issues and legislation associated with opioids. Outreach and monitoring related to Tricare reimbursement H.R. 3107 Improving Seniors Timely Access to Care Act of 2019 SENATE 30000   0 0 2020-04-16T12:48:08.867000-04:00
2428385 STANFORD UNIVERSITY f73f469e-c459-46f2-8f49-168f482bf527 Q1 STANFORD UNIVERSITY 36492 STANFORD UNIVERSITY 2020 first_quarter MED HR6074 Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020 HR6201 Families First Coronavirus Response Act of 2020 HR748 Coronavirus Aid Relief and Economic Security Act of 2020 Health Professions Programs Graduate Medical Education Funding Pediatric GME Programs Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE,State, Dept of (DOS)   90000 0 0 2020-04-16T12:54:17.447000-04:00
2428440 SQUIRE PATTON BOGGS d0074289-5471-4dc6-9b74-829cade4bd18 Q1 SQUIRE PATTON BOGGS 30906 THOMAS JEFFERSON UNIVERSITY 2020 first_quarter MED Advancing health system legislative and regulatory issues including: the development of a collaborative, interdisciplinary translational cancer research program; develop the Partners in Innovation, Education, and Research (PIER) program. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2020-04-16T13:05:32.380000-04:00
2428929 INFECTIOUS DISEASES SOCIETY OF AMERICA 7d6e0416-bc09-4311-b9cf-606b536db2b6 Q1 INFECTIOUS DISEASES SOCIETY OF AMERICA 54836 INFECTIOUS DISEASES SOCIETY OF AMERICA 2020 first_quarter MED Medical liability; antimicrobial resistance research, infectious disease product R&D regulatory science, unnecessary regulatory burdens placed on medical research; laboratory developed tests; comparative effectiveness research; support for evidence-based decision making; point-of-care diagnostic tests; and organ transplant policies to allow HIV+ to HIV+ organ transplants. Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE   90000 0 0 2020-04-16T14:48:09.497000-04:00
2429026 NATIONAL MULTIPLE SCLEROSIS SOCIETY 786c19a1-a277-4fae-8c2d-9ec3640890ee Q1 NATIONAL MULTIPLE SCLEROSIS SOCIETY 69674 NATIONAL MULTIPLE SCLEROSIS SOCIETY 2020 first_quarter MED N/A HOUSE OF REPRESENTATIVES,SENATE   132919 0 0 2020-04-16T15:05:34.130000-04:00
2429255 THE CONAFAY GROUP, LLC 9068b786-79d6-448c-9361-91c7968fb382 Q1 THE CONAFAY GROUP, LLC 401004840 PREACTIVE TECHNOLOGIES, INC. 2020 first_quarter MED Traumatic Brain Injury Prevention HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2020-04-16T16:12:44.697000-04:00
2429276 THE CONAFAY GROUP, LLC d4e1b866-4565-4499-87f4-24a1cb4bed12 Q1 THE CONAFAY GROUP, LLC 401004840 PHLOW CORPORATION 2020 first_quarter MED US pharmaceutical manufacturing Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2020-04-16T16:21:50.700000-04:00
2429352 THE CONAFAY GROUP, LLC c9fe9621-38d8-45c4-aa8b-4490e164f6e5 Q1 THE CONAFAY GROUP, LLC 401004840 ACADIA PHARMACEUTICALS INC. 2020 first_quarter MED Pharmaceutical research. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2020-04-16T16:50:11.507000-04:00
2429458 THE CONAFAY GROUP, LLC dd08857e-de3a-4704-9aa2-143da22d6b4c Q1 THE CONAFAY GROUP, LLC 401004840 CIDARA THERAPEUTICS, INC. 2020 first_quarter MED Support for research on viral diseases HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2020-04-16T17:14:36.237000-04:00
2429718 FAEGRE BAKER DANIELS CONSULTING 01658314-a9df-48ec-9bf0-a5ad0e893b44 1T FAEGRE BAKER DANIELS CONSULTING 34158 GLOBAL DOWN SYNDROME FOUNDATION 2020 first_quarter MED Fiscal Year 2021 Labor HHS appropriations for Down Syndrome Research; NIH research funding HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE     0 1 2020-04-16T19:30:57.277000-04:00
2429903 VAN SCOYOC ASSOCIATES 7b954993-6bfb-4409-85cf-2152fd90cf22 Q1 VAN SCOYOC ASSOCIATES 39837 ARUP LABORATORIES, INC. 2020 first_quarter MED H.R.6102, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020, Diagnostic Lab Testing COVID-19 Laboratory Testing related issues, as follows: Public Law 116-123, Coronavirus Preparedness and Response Supplemental Appropriations Act, FY2020 Public Law 116-127, Families First Coronavirus Response Act Public Law 116-136, Coronavirus Aid, Relief, and Economic Security (CARES) Act HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2020-04-17T06:07:49.727000-04:00
2429909 VAN SCOYOC ASSOCIATES 4a523543-dd1a-44da-9635-7ea1d1d974bb Q1 VAN SCOYOC ASSOCIATES 39837 MEDICAL COLLEGE OF WISCONSIN 2020 first_quarter MED Healthcare research and development related issues, as follows: Energy and Water Development and Related Agencies Appropriations Act, FY2021 Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, FY2021 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, FY2021 HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2020-04-17T06:10:50.967000-04:00
2429981 VAN SCOYOC ASSOCIATES fa9514ec-268b-4f4b-9c67-28933614748f Q1 VAN SCOYOC ASSOCIATES 39837 MEDICAL UNIVERSITY HOSPITAL AUTHORITY 2020 first_quarter MED Medical research and development related issues: National Institutes of Health, and various institutes and bureaus thereof Health Resources Services Administration HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2020-04-17T07:13:09.483000-04:00
2430092 VAN SCOYOC ASSOCIATES b50f210f-06db-499a-9949-66c5c5cf23a1 Q1 VAN SCOYOC ASSOCIATES 39837 GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION 2020 first_quarter MED CDC, Infectious Diseases Research Centers in Minority Institutions E-Cigarettes related issues Public Law 116-123, Coronavirus Preparedness and Response Supplemental Appropriations Act, FY2020, Higher Education research related issues; and SARS-CoV2 issues Public Law 116-136, Coronavirus Aid, Relief, and Economic Security (CARES) Act, Higher Education research related issues; and SARS-CoV2 issues Monitor the following: Agency for Healthcare Research and Quality Medicaid Disparities NIH Public Health HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2020-04-17T08:02:31.727000-04:00
2430116 CAPITOL DECISIONS, INC. c400832a-00a9-4857-be63-58b44c600609 Q1 CAPITOL DECISIONS, INC. 55165 VAN SCOYOC ASSOCIATES (MEDICAL UNIVERSITY HOSPITAL AUTHORITY) 2020 first_quarter MED Medical reseerach and development related isssues National Institutes of Health, and various institutes and bureaus thereof Health Resources Services Administration HOUSE OF REPRESENTATIVES,SENATE     0 0 2020-04-17T08:15:34.047000-04:00
2430360 BRACEWELL LLP 0f0f76d4-f7fe-493e-8d05-6e238dd14a8c Q1 BRACEWELL LLP 6837 NATIONAL BRAIN TUMOR SOCIETY 2020 first_quarter MED work related to the advancement of the Cancer Drug Coverage Parity Act and PCHETA (H.R. 647); Peer-review cancer research; Drug pricing and shortages; COVID-19 Response Issues HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2020-04-17T10:00:30.027000-04:00
2430363 GOLDBUG STRATEGIES LLC eb7a3e9d-8fe1-4bc3-b3b8-a697b50fe4bb 1T GOLDBUG STRATEGIES LLC 400701094 23ANDME, INC. 2020 first_quarter MED in vitro diagnostics, clinical laboratories, digital health regulation Food & Drug Administration (FDA)     0 1 2020-04-17T10:00:30.593000-04:00
2430432 WINNING STRATEGIES WASHINGTON 5bc22f55-3bbd-4f05-a665-dd87d512dbb2 Q1 WINNING STRATEGIES WASHINGTON 50796 I AM ALS 2020 first_quarter MED Funding for ALS research in annual Defense and Labor-HHS-Education appropriations bills Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2020-04-17T10:14:48.727000-04:00
2430499 UNIVERSITY OF IOWA 92344024-7f13-47b5-95cb-dbfb0850ab00 Q1 UNIVERSITY OF IOWA 49191 UNIVERSITY OF IOWA 2020 first_quarter MED Support for federal agencies that fund medical and disease research Support for increased federal funding for research and response efforts in response to COVID-19 Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Oceanic & Atmospheric Administration (NOAA),SENATE   70000 0 0 2020-04-17T10:23:06.180000-04:00
2430595 GOLDBUG STRATEGIES LLC 9a43106d-4222-43d2-9146-5c563683b1b9 Q1 GOLDBUG STRATEGIES LLC 400701094 COALITION FOR 21ST CENTURY MEDICINE 2020 first_quarter MED in vitro diagnostics, clinical laboratories, digital health regulation Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 19500   0 0 2020-04-17T10:35:24.453000-04:00
2430652 WINNING STRATEGIES WASHINGTON 45c5153b-427c-496d-a3d3-f16ecb58a517 Q1 WINNING STRATEGIES WASHINGTON 50796 PHLOW CORPORATION 2020 first_quarter MED Domestic manufacturing of essential generic medicines; supply chain disruptions and shortages of foreign manufactured medicines HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2020-04-17T10:43:36.113000-04:00
2430749 MCDERMOTT WILL & SCHULTE LLP 2c782acb-940a-480f-8fc5-7ca433670f82 Q1 MCDERMOTT WILL & SCHULTE LLP 24338 MAYO CLINIC 2020 first_quarter MED Issues impacting academic medical centers. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2020-04-17T10:55:55.773000-04:00
2430776 WINNING STRATEGIES WASHINGTON f4b4e056-680a-4b62-934a-f75a522e7ad5 Q1 WINNING STRATEGIES WASHINGTON 50796 RETRACTABLE TECHNOLOGIES INC (RTI) 2020 first_quarter MED Response to COVID-19 HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2020-04-17T11:04:06.210000-04:00
2430785 OAK RIDGE ASSOCIATED UNIVERSITIES, INC. d598c5c8-1a4a-488d-ad14-ca68b9656a67 Q1 OAK RIDGE ASSOCIATED UNIVERSITIES, INC. 401104196 OAK RIDGE ASSOCIATED UNIVERSITIES, INC. 2020 first_quarter MED NIH funding for aging science, tobacco and peer review activities Defense, Dept of (DOD),Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   30000 0 0 2020-04-17T11:04:07.350000-04:00
2431224 MUTUAL OF OMAHA 59351be5-0e57-4200-8244-535f5dcc6a49 Q1 MUTUAL OF OMAHA 26284 MUTUAL OF OMAHA 2020 first_quarter MED HR 5826; Consumer Protection Against Surprise Medical Bills Act. Several proposals were introduced this Congress to address surprise billing: H.R. 861 - End Surprise Billing Act 2019; H.R. 3502-Protecting People From Surprise Medical Billing Act; H.R. 3630 - No Surprise Act; H.R. 4223 - Protecting Patients from Surprise Medical Bills; S. 1266 - Protecting Patients from Surprise Medical Bills Act; S. 1531, Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; and S. 1895 - Lower Health Care Costs Act. This legislation, with H.R. 5800 - Ban Surprise Billing Act, received more traction and establishes a process for arbitration. HR 5800; Ban Surprise Billing Act. Several proposals were introduced this Congress to address surprise billing: H.R. 861 - End Surprise Billing Act 2019; H.R. 3502-Protecting People From Surprise Medical Billing Act; H.R. 3630 - No Surprise Act; H.R. 4223 - Protecting Patients from Surprise Medical Bills; S. 1266 - Protecting Patients from Surprise Medical Bills Act; S. 1531, Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; and S. 1895 - Lower Health Care Costs Act. This legislation, with H.R. 5826 - Consumer Protection Against Surprise Medical Bills Act, would use a market-based benchmark of the local median in-network rate for amounts less than or equal to $750 and allows providers and payers to elect an arbitration process for any amounts for which the median in-network rate is above that threshold. HOUSE OF REPRESENTATIVES,SENATE   90000 0 0 2020-04-17T11:50:42.490000-04:00
2431249 WILLIAMS AND JENSEN, PLLC 5fb8e525-37b6-4464-9862-1549f2ddab20 Q1 WILLIAMS AND JENSEN, PLLC 41454 GLOBAL DOWN SYNDROME FOUNDATION 2020 first_quarter MED Support for down syndrome research funding. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office 40000   0 0 2020-04-17T11:54:47.037000-04:00
2431394 FAEGRE DRINKER BIDDLE & REATH LLP d6b2c39c-4367-4012-820f-490b113b1ab3 Q1 FAEGRE DRINKER BIDDLE & REATH LLP 12631 DRUGS FOR NEGLECTED DISEASES INITIATIVE OF NORTH AMERICA 2020 first_quarter MED Issues related to anti-microbial resistance and neglected tropical diseases.   10000   0 0 2020-04-17T12:14:24.143000-04:00
2431742 THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH 0951fdd4-815e-486e-aaa8-d113b8dc5cc5 Q1 THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH 314055 THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH 2020 first_quarter MED Support for Medical Research Funding Programs at the National Institutes of Health, the National Eye Institute, and the Department of Defense HOUSE OF REPRESENTATIVES,SENATE   65583 0 0 2020-04-17T12:58:01.760000-04:00
2431792 MASSACHUSETTS BIOTECHNOLOGY COUNCIL 4f1da57a-bb66-4faa-9828-597be39adf0a Q1 MASSACHUSETTS BIOTECHNOLOGY COUNCIL 400271247 MASSACHUSETTS BIOTECHNOLOGY COUNCIL 2020 first_quarter MED Meetings regarding proposed changes to Medicare Part B and Medicare Part D reimbursement that negatively impact patient access to innovative therapies. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Patent & Trademark Office (PTO),SENATE   25000 0 0 2020-04-17T13:12:15.377000-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 2283.419ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API